Both ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) patients & Long Covid patients are excited about the upcoming Berlin Cures 007 treatment. Many believe this could be a game-changing/breakthrough treatment for patients with these conditions and one which could improve quality of life substantially (or better than that). BC007 is an infusion which uses an ‘aptamer’ drug in order to neutralise the specific functional autoantibodies that are causing symptoms in these illnesses. This is an example therefore of precision medicine and a research breakthrough that could help heal/improve patients with these illnesses. In this video, we talk about DNA aptamer drugs, how BC007 works for LC, what we know about it so far, how it cured four Long Covid patients and the phase II trial that is currently ongoing.
Affiliates:
Normalyte (most helpful supplement I've ever found for ME/CFS) - affiliate link: normalyte.com/...
DNRS Brain retraining (helped me recover from my first round of illness and still very much recommended) affiliate link - retrainingtheb...
Timestamps
1:00 introduction
2:08 BC007
5:07 a cure?
7:20 Four LC patients recover post-drug
8:40 BC Progress
11:25 final thoughts
My name is Patrick Ussher and I am an ME/CFS patient. I have written a book on POTS and also about thirst in ME/CFS, POTS and Long Covid.
Personal website (including details about consultations service): www.patrickussher.com
My (free) book on thirst in ME/CFS, POTS, LC: www.themythofprimarypolydipsia.com
NB: This video is for educational purposes only - please always consult a doctor about any health issues or changes.
Links mentioned in this video:
www.celltrend.de
www.berlincures.com
LC patients experience post BC007 - www.fau.eu/202...
Autoantibodies in ME/CFS correlate with symptom severity - pubmed.ncbi.nl...
Негізгі бет GAME-CHANGING treatment for ME/CFS, Long Covid patients? All about Berlin Cures 007
Пікірлер: 53